Lv6
2160 积分 2022-11-29 加入
EGFR-TKI相关口腔黏膜炎的中西医诊治研究进展
1天前
待确认
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
10天前
已完结
Sacituzumab Tirumotecan in Participants With Advanced or Metastatic Urothelial Carcinoma and Disease Progression after Chemotherapy and Immune Checkpoint Inhibitors
16天前
已完结
复发性子宫内膜癌临床诊疗进展
1个月前
已完结
A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) – design and rationale
2个月前
已完结
Antibody-Drug Conjugates in urothelial, prostate, and renal cell cancers: A review of current and emerging therapies
2个月前
已完结
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial
2个月前
已完结
Real-world applications of PARPi maintenance therapy for recurrent ovarian cancer: A single-center study in China
2个月前
已关闭
Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with HER2-expressing muscle-invasive bladder cancer (MIBC) in the phase II RC48-C017 trial: Updated results
3个月前
已关闭
皖公网安备34019202002308
